Posted on November 4, 2010 by Albin Paul
Dr. Mehdi Khalid Vice President, Healthcare and Life Sciences Industry Business Unit Asia Pacific and Japan at Oracle about key aspects of healthcare IT market in India & Oracle’s presence in this space. DownloadHealth India 2010
Filed under: Health Sciences Global Business Unit, Healthcare IT, HSGBU, oracle, Oracle Health Sciences Global Business Unit | Tagged: health sciences global business unit, healthcare IT, HSGBU, oracle, Oracle Health Science Global Business Unit, Oracle Healthcare, Oracle HSGBU | Leave a Comment »
Posted on September 30, 2010 by Albin Paul
The Institute is focused on research that will accelerate IT innovation to advance personalized medicine and the delivery of safe and effective treatments and health care services to patients around the globe. OHSI will work in tandem with academic research centers, focusing on a targeted set of research areas fundamental to the R&D and [...]
Filed under: Drug Safety, genetic medicine, Online Data sharing, open access database, open source, oracle, Oracle Health Sciences Global Business Unit, Patient Safety, personalized medicine, Pharmacogenomics, pharmacovigilance | Tagged: Drug Safety, health sciences global business unit, HSGBU, OHSI, Open Source Drug Development Network, oracle, Oracle Health Science Global Business Unit, Oracle Health Sciences Institute, personalized medicine, Pharmacogenomics, pharmacovigilance, Sun Labs | 1 Comment »
Posted on September 6, 2010 by Albin Paul
Learn more about the strategic dynamics of Life Sciences at Oracle Open World 2010, from September 19-23. Attend the Life Sciences track to learn how Oracle’s powerful combination of technology and comprehensive business applications can help you address key challenges such as costly, high-risk discovery periods and shrinking patent expiration limits. Leading life sciences organizations will discuss how [...]
Filed under: Health Sciences Global Business Unit, oracle, Oracle Health Sciences Global Business Unit | Tagged: clinical research, Drug Development, health sciences global business unit, Lifescience, lifescience cloud, Oracle health sciences global business unit | Leave a Comment »
Posted on August 10, 2010 by Albin Paul
Single patient Clinical Trial are not new idea, FDA did not focus since such trial canot prove the efficacy and safety of medicine over a large pool of patient with sufficient data. But I was forced to re-think after reading the article http://www.technologyreview.in/biomedicine/12537/ why cant we use the the concept mentioned in to overcome the [...]
Filed under: clinical research, Clinical Trial, Patient Safety, personalized medicine, pharmacovigilance | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »
Posted on June 18, 2010 by Albin Paul
http://newsroom.gehealthcare.com/ GE Health Care is rolling out a new, cloud-based platform that makes it easier for physicians with small practices to maintain and keep track of the electronic medical records of their patients. The new SAAS offering is part of GE’s Centricity offering. Introducing Centricity Advance Colonnades Family Medicine is running on Centricity Advance, a [...]
Filed under: cloud computing, SaaS | Tagged: cloud computing, EHR, EMR, health sciences global business unit, healthcare IT, Oracle health sciences global business unit, SaaS, Software-as-a-Service | 4 Comments »
Posted on June 18, 2010 by Albin Paul
http://www.cioupdate.com/features/article.php/3888281/IBM-Volunteers-Help-Locate-Anti-Cancer-Drugs.htm
Filed under: cloud computing, collaborative research, open source, SaaS, web2.0 | Tagged: cloud computing, grid computing, health sciences global business unit, lifescience cloud, open source, Oracle health sciences global business unit, SaaS | Leave a Comment »
Posted on June 18, 2010 by Albin Paul
The Australian Research Collaboration Service (ARCS) www.arcs.org.au has launched its Computer Cloud scheme, a $22 million project funded by the government’s National Collaborative Research Infrastructure Strategy. More details check http://www.arcs.org.au/index.php/services/cloud-computing Bob Correll, the chief information officer for the Department of Immigration and Citizenship, said his agency is also looking into using cloud computing for its [...]
Filed under: clinical software, cloud computing, lifescience, Online Data sharing, open source, SaaS | Tagged: health sciences global business unit, Oracle health sciences global business unit | Leave a Comment »
Posted on June 10, 2010 by Albin Paul
GlaxoSmithKline has teamed up with MedTrust Online, provider of specialist data and technology to oncologists, to launch CancerTrialsApp, described as “the first free geo locating cancer clinical trials application” for the Apple iPhone and iPad. The application enables cancer doctors to find and share with their patients information about experimental therapies in clinical trials
Filed under: clinical informatics, clinical research, clinical software, Clinical Trial, Visual Clinica | Tagged: health sciences global business unit, Oracle health sciences global business unit | Leave a Comment »
Posted on April 14, 2010 by Albin Paul
Plans by FDA to Adopt stricter standards for Bioequivalence, Bioavailability for generic drugs could sound trouble for Indian Generic Manufactures. Already most of the smaller companies are finding it difficult to get FDA approval letters. QSR Draft Guidance An industry working group has urged the FDA to consider adopting its guidance to outline quality system [...]
Filed under: microarray | Tagged: bioavailability, bioequivalence, health sciences global business unit, Oracle health sciences global business unit | Leave a Comment »
Posted on February 2, 2010 by Albin Paul
Jonathan West a micro-engineer and his colleagues at the University of Dortmund in Germany, has developed the new microarray chip which can test an estimated 30,000 chemicals their toxicological risk. Called a Network Formation Assay (NFA), the chip lets researchers test compounds faster and more reliably. A normal drug test takes up to 10 hours [...]
Filed under: microarray, Next Generation Drug Development, Next Generation of DNA and RNA Microarrays | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »
Posted on February 2, 2010 by Albin Paul
The FDA unveiled phase 1 of its transparency initiative with the launch of FDA Basics, a microsite aimed at demystifying the agency’s workings for the public. It’s the first of a 3 phase transparency initiative launched FDA as part of the Obama Administration’s broader commitment to openness. Phase 2, will deal with disclosure of sensitive information [...]
Filed under: pharmacovigilance | Tagged: FDA, health sciences global business unit, Oracle health sciences global business unit, post market surveillance | Leave a Comment »
Posted on December 20, 2009 by Albin Paul
NVIDIA and Notion Ink, launches ‘Adam’, a touch screen tablet at the Las Vegas Consumer Electronics Show in January 2010, a high-tech IT product that was completely developed in India, marking the country’s big entry into product development. With NVIDIA’s Tegra system-on-chip at its heart, Adam is a device the new generation technology user dreams [...]
Filed under: digital, digital DNA, science and entertainment, visual genomics, web2.0 | Tagged: health sciences global business unit, Oracle health sciences global business unit | 3 Comments »
Posted on December 15, 2009 by Albin Paul
I have got too lazy after I started using twitter. So instead of posting news story in my blog I just updated my twitter @clinicalsearch about Dr Josh Mylne from the Institute for Molecular Bioscience (IMB) at University of Queensland receiving research fund to support research on plants to produce pharmaceutical drugs http://digs.by/10R9 My first thoughts [...]
Filed under: Genetically modified, transgenomics | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »
Posted on December 4, 2009 by Albin Paul
I am not concerned about the number of mistakes made in UK hospitals. As a pharmacist I am concerned, if UK has such a high rate of medication errors, then what would be the rates in countries like India, where Pharmacists almost never over ride the prescriptions and physicians treat more than 100 patients every [...]
Filed under: Drug Safety, Patient Safety | Tagged: health sciences global business unit, medication erros, Oracle health sciences global business unit | Leave a Comment »
Posted on December 4, 2009 by Albin Paul
Hit with allegations in the western media about unethical practices in conducting clinical trials, The Indian government and regulatory authorities are making a bolder move planning mandatory biometric identification for clinical trial volunteers in India. The Ministry of Health and Family Welfare plans to ask all clinical research organisations to enforce biometric identification for the [...]
Filed under: Clinical Trial, Next Generation Clinical Trial, Next Generation Drug Development, Next Generation Drug Discovery | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »
Posted on November 30, 2009 by Albin Paul
Ben Goldacre @bengoldacre argues that the financial interests of drug companies lead to distorted evidence, but Vincent Lawton believes that adequate safeguards exist to keep bias in check. Full text of the article is published on BMJ Dr Goldacre and Prof Lawton faced each other on the same issue recently as opposing speakers at PharmaTimes’s Great Oxford [...]
Filed under: Next Generation Clinical Trial, Next Generation Drug Discovery | Tagged: collaborative drug development, collaborative drug discovery, health sciences global business unit, Oracle health sciences global business unit | Leave a Comment »
Posted on November 29, 2009 by Albin Paul
The Coverage of the World Ecconomic Forum India Economic Summit is available at http://blog.livemint.com/wefindia/ I was more interested in the Collaborative Strategy for Drug Development read the interview with Suven Lifesciences a prefered partner to Eli Lilly and Co in Drug Discoverya dn Development in India. http://www.livemint.com/2009/11/10204140/India-Economic-Summit–Collab.html
Filed under: drug development, drug discoverry, Next Generation Drug Discovery | Tagged: collaborative drug development, collaborative drug discovery, health sciences global business unit, Oracle health sciences global business unit | Leave a Comment »
Posted on November 24, 2009 by Albin Paul
The National Library of Medicine wants health care organizations and vendors to test drive its new mapping tool that covers 5,000 standardized clinical terms , to create a standard medical vocabulary to support applications for electronic health records The Obama administration is distributing more than $19 billion in payments to doctors and hospitals that buy [...]
Filed under: clinical informatics, clinical software, Healthcare Informatics | Tagged: EHR, EMR, health sciences global business unit, ICD-9, Oracle health sciences global business unit, SNOMED | Leave a Comment »
Posted on November 23, 2009 by Albin Paul
There has been a flurry of discussion around social media and its implication in the last few months , So I thought it would be good to have some of these arguments laid out in one single post. Social Media has entered every business and industry even, inside the US Intelligence Community, who sorted out [...]
Filed under: six degrees of separation, social Media | Tagged: compliance, facebook, FDA, health sciences global business unit, linkedin, oracle, Oracle health sciences global business unit, SAP, SEC, twitter | Leave a Comment »
Posted on November 20, 2009 by Albin Paul
“My sales people are wasting valuable time on Facebook and Linkedin when they should be selling”: Now thats what most sales managers would say. I know thats true , I have irritated fare share of my managers by using social media to create and close sales and in lead generation. And I continue to do [...]
Filed under: microarray, six degrees of separation, social Media, web2.0 | Tagged: facebook, health sciences global business unit, linkedin, Oracle health sciences global business unit, social networking | Leave a Comment »